维生素D对终末期肾病患者心血管保护研究进展(4)
[7] 肖硕，文九芳.基因敲除技术在维生素D受体研究中的应用进展.新医学，2016，47(6)：354?356.
[8] Pelham CJ，Drews EM，Agrawal DK.Vitamin D controls resistance artery function through regulation of perivascular adipose tissue hypoxia and inflammation. J Mol Cell Cardiol，2016，98：1?10.
[9] Lin LM，Peng F，Liu YP，Chai DJ，Ning RB，Xu CS，Lin JX.Coadministration of VDR and RXR agonists synergistically alleviates atherosclerosis through inhibition of oxidative stress： An in vivo and in vitro study. Atherosclerosis，2016，251：273?281.
, 百拇医药
[10] Brndum?Jacobsen P，Nordestgaard BG，Schnohr P，Benn M.25?hydroxyvitamin D and symptomatic ischemic stroke： an original study and meta?analysis. Ann Neurol，2013，73(1)：38?47.
[11] Arnson Y，Itzhaky D，Mosseri M，Barak V，Tzur B，Agmon?Levin N，Amital H.Vitamin D inflammatory cytokines and coronary events： a comprehensive review. Clin Rev Allergy Immunol，2013，45(2)：236?247.
[12] van Ballegooijen AJ，Reinders I，Visser M，Brouwer IA.Parathyroid hormone and cardiovascular disease events： a systematic review and meta?analysis of prospective studies. Am Heart J，2013，165(5)：655?664，664.e1?5.
, 百拇医药
[13] Itoh H，Mori I，Matsumoto Y，Maki S，Ogawa Y.Vitamin D deficiency and seasonal and inter?day variation in circulating 25?hydroxyvitamin D and parathyroid hormone levels in indoor daytime workers： a longitudinal study. Ind Health，2011，49(4)：475?481.
[14] Ketteler M，Martin KJ，Wolf M，Amdahl M，Cozzolino M，Goldsmith D，Sharma A，Marx S，Khan S.Paricalcitol versus cinacalcet plus low?dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis： results of the IMPACT SHPT study. Nephrol Dial Transplant，2012，27(8)：3270?3278.
, http://www.100md.com
[15] Shin HC，Jang JS，Jin HY，Seo JS，Yang TH，Kim DK，Kim DS.Combined use of neutrophil to lymphocyte ratio and C?reactive protein level to predict clinical outcomes in acute myocardial infarction patients undergoing percutaneous coronary intervention. Korean Circ J，2017，47(3)：383?391.
[16] Rodriguez AJ，Mousa A，Ebeling PR，Scott D，de Courten B.Effects of vitamin D supplementation on inflammatory markers in heart failure： a systematic review and meta?analysis of randomized controlled trials. Sci Rep，2018，8(1)：1169.
[17] Song Y，Hong J，Liu D，Lin Q，Lai G.1，25?dihydroxyvitamin D3 inhibits nuclear factor kappa B activation by stabilizing inhibitor IκBα via mRNA stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells. Scand J Immunol，2013，77(2)：109?116., 百拇医药(冯世栋 田秀娟 王妍 王汉民)
[8] Pelham CJ，Drews EM，Agrawal DK.Vitamin D controls resistance artery function through regulation of perivascular adipose tissue hypoxia and inflammation. J Mol Cell Cardiol，2016，98：1?10.
[9] Lin LM，Peng F，Liu YP，Chai DJ，Ning RB，Xu CS，Lin JX.Coadministration of VDR and RXR agonists synergistically alleviates atherosclerosis through inhibition of oxidative stress： An in vivo and in vitro study. Atherosclerosis，2016，251：273?281.
, 百拇医药
[10] Brndum?Jacobsen P，Nordestgaard BG，Schnohr P，Benn M.25?hydroxyvitamin D and symptomatic ischemic stroke： an original study and meta?analysis. Ann Neurol，2013，73(1)：38?47.
[11] Arnson Y，Itzhaky D，Mosseri M，Barak V，Tzur B，Agmon?Levin N，Amital H.Vitamin D inflammatory cytokines and coronary events： a comprehensive review. Clin Rev Allergy Immunol，2013，45(2)：236?247.
[12] van Ballegooijen AJ，Reinders I，Visser M，Brouwer IA.Parathyroid hormone and cardiovascular disease events： a systematic review and meta?analysis of prospective studies. Am Heart J，2013，165(5)：655?664，664.e1?5.
, 百拇医药
[13] Itoh H，Mori I，Matsumoto Y，Maki S，Ogawa Y.Vitamin D deficiency and seasonal and inter?day variation in circulating 25?hydroxyvitamin D and parathyroid hormone levels in indoor daytime workers： a longitudinal study. Ind Health，2011，49(4)：475?481.
[14] Ketteler M，Martin KJ，Wolf M，Amdahl M，Cozzolino M，Goldsmith D，Sharma A，Marx S，Khan S.Paricalcitol versus cinacalcet plus low?dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis： results of the IMPACT SHPT study. Nephrol Dial Transplant，2012，27(8)：3270?3278.
, http://www.100md.com
[15] Shin HC，Jang JS，Jin HY，Seo JS，Yang TH，Kim DK，Kim DS.Combined use of neutrophil to lymphocyte ratio and C?reactive protein level to predict clinical outcomes in acute myocardial infarction patients undergoing percutaneous coronary intervention. Korean Circ J，2017，47(3)：383?391.
[16] Rodriguez AJ，Mousa A，Ebeling PR，Scott D，de Courten B.Effects of vitamin D supplementation on inflammatory markers in heart failure： a systematic review and meta?analysis of randomized controlled trials. Sci Rep，2018，8(1)：1169.
[17] Song Y，Hong J，Liu D，Lin Q，Lai G.1，25?dihydroxyvitamin D3 inhibits nuclear factor kappa B activation by stabilizing inhibitor IκBα via mRNA stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells. Scand J Immunol，2013，77(2)：109?116., 百拇医药(冯世栋 田秀娟 王妍 王汉民)